- Report
- September 2024
- 250 Pages
Global
From €3903EUR$3,995USD£3,259GBP
- Report
- October 2024
- 191 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- October 2024
- 191 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- October 2024
- 51 Pages
Global
€1363EUR$1,395USD£1,138GBP
- Report
- July 2024
- 115 Pages
Global
From €4641EUR$4,750USD£3,874GBP
- Report
- March 2023
Global
From €6253EUR$6,400USD£5,220GBP
- Report
- March 2023
Global
From €6253EUR$6,400USD£5,220GBP
- Report
- July 2020
- 164 Pages
Global
From €1209EUR$1,238USD£1,009GBP
€2418EUR$2,475USD£2,019GBP
- Report
- February 2018
- 135 Pages
Global
From €4885EUR$5,000USD£4,078GBP
- Report
- January 2018
- 59 Pages
Global
From €2926EUR$2,995USD£2,443GBP
- Report
- January 2022
- 41 Pages
Global
- Report
- January 2023
- 44 Pages
Global
From €1466EUR$1,500USD£1,224GBP
- Report
- January 2021
- 43 Pages
Global
From €484EUR$495USD£404GBP
- Training
- 60 Minutes
Canada
- Training
- 90 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 60 Minutes
Global
Pharmacoeconomics is a branch of economics that studies the cost-effectiveness of pharmaceutical products and services. It is used to assess the value of a drug or medical intervention in terms of its impact on patient outcomes, healthcare costs, and quality of life. Pharmacoeconomics is used to inform decisions about which drugs and treatments should be used in clinical practice, and to assess the cost-effectiveness of different healthcare interventions.
Pharmacoeconomics is a growing field, with many companies offering services to help healthcare providers and payers make informed decisions about drug and treatment selection. Companies in this market include Express Scripts, OptumRx, CVS Health, and Prime Therapeutics. These companies provide services such as cost-effectiveness analysis, drug utilization review, and formulary management. They also offer consulting services to help healthcare providers and payers make informed decisions about drug and treatment selection. Show Less Read more